Search - tctmd.com

Displaying 261 - 280 of 389

Sort: Relevancy | Date

News Daily News

End-Diastolic FFR More Accurate than Conventional Version in Preclinical Study

February 12, 2014

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

Presentation

Therapeutic Alternatives to Intracoronary Thrombus: The MASTER Results in Perspective

Presenter: Gregg W. Stone

December 01, 2013

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Conference News AHA 2013

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Yael L. Maxwell

November 20, 2013

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Conference News TCT 2013

TCT Honors Bernhard Meier with the Hartzler Master Clinical Operator Award

October 30, 2013

News Conference News TCT 2013

Novel Ischemia Measurement Strategies Show Potential vs. FFR

October 30, 2013

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

Presenter: Alejandro Fernandez

October 29, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

CADUCEUS: Células madre autólogas revierten de manera segura algunos daños del IM

September 27, 2013

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Daily News

Meta-analysis: Cell Therapy Improves LV Function in Majority of STEMI Patients

Jason Kahn

September 20, 2013

News Daily News

Meta-análisis: Terapia con célula mejora la función del ventrículo izquierdo en la mayoría de los pacientes con STEMI

Jason Kahn

September 20, 2013

Presentation

Impact of Intracoronary Bone Marrow Cell Therapy on LV Function in the Setting of STEMI

Presenter: Ronak Delewi

September 16, 2013

Advertisement

End-Diastolic FFR More Accurate than Conventional Version in Preclinical Study

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Therapeutic Alternatives to Intracoronary Thrombus: The MASTER Results in Perspective

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

French Registry: FFR Safely Reclassifies Almost Half of Revascularization Patients

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

TCT Honors Bernhard Meier with the Hartzler Master Clinical Operator Award

Novel Ischemia Measurement Strategies Show Potential vs. FFR

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Case #1: Management of Residual Thrombus After Intracoronary Administration of Abciximab and Manual Thromboaspiration in STEMI.

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

CADUCEUS: Células madre autólogas revierten de manera segura algunos daños del IM

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Meta-analysis: Cell Therapy Improves LV Function in Majority of STEMI Patients

Meta-análisis: Terapia con célula mejora la función del ventrículo izquierdo en la mayoría de los pacientes con STEMI

Impact of Intracoronary Bone Marrow Cell Therapy on LV Function in the Setting of STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content